Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Tesla
TSLA
|
+$877M |
| 2 |
Marvell Technology
MRVL
|
+$723M |
| 3 |
KKR & Co
KKR
|
+$502M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$393M |
| 5 |
SW
Smurfit Westrock plc
SW
|
+$380M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$1.45B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.15B |
| 3 |
Apple
AAPL
|
+$592M |
| 4 |
Charles Schwab
SCHW
|
+$491M |
| 5 |
Amazon
AMZN
|
+$438M |
Sector Composition
| 1 | Technology | 31.86% |
| 2 | Financials | 12.66% |
| 3 | Consumer Discretionary | 11.93% |
| 4 | Healthcare | 9.58% |
| 5 | Communication Services | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Kaiser Aluminum
KALU
$1.24B
| $3.06M | ﹤0.01% |
43,587
-5,964
| -12% | -$419K |
|
2177
Hanmi Financial
HAFC
$748M
| $3.05M | ﹤0.01% |
129,024
-14,579
| -10% | -$344K |
|
2178
Intellia Therapeutics
NTLA
$1.23B
| $3.04M | ﹤0.01% |
260,697
-105,170
| -29% | -$1.23M |
|
2179
PRA Group
PRAA
$657M
| $3.04M | ﹤0.01% |
145,414
+15,153
| +12% | +$317K |
|
2180
Universal Corp
UVV
$1.38B
| $3.03M | ﹤0.01% |
55,335
| – | – |
|
2181
Novavax
NVAX
$1.3B
| $3.03M | ﹤0.01% |
376,968
-47,651
| -11% | -$383K |
|
2182
Zymeworks
ZYME
$1.19B
| $3.03M | ﹤0.01% |
207,023
+886
| +0.4% | +$13K |
|
2183
Malibu Boats
MBUU
$629M
| $3.02M | ﹤0.01% |
80,431
-2,401
| -3% | -$90.3K |
|
2184
AMN Healthcare
AMN
$699M
| $3.02M | ﹤0.01% |
126,389
-29,344
| -19% | -$702K |
|
2185
AdaptHealth
AHCO
$1.26B
| $3.01M | ﹤0.01% |
316,108
+69,050
| +28% | +$657K |
|
2186
Wolfspeed
WOLF
$365M
| $3M | ﹤0.01% |
450,356
-204,897
| -31% | -$1.36M |
|
2187
MiMedx Group
MDXG
$1.03B
| $2.98M | ﹤0.01% |
309,878
| – | – |
|
|
CIM
2188
Chimera Investment
CIM
$1.15B
| $2.95M | ﹤0.01% |
210,664
-3,544
| -2% | -$49.6K |
|
2189
Leggett & Platt
LEG
$1.3B
| $2.94M | ﹤0.01% |
305,875
+51,733
| +20% | +$497K |
|
|
PINE
2190
Alpine Income Property Trust
PINE
$208M
| $2.93M | ﹤0.01% |
174,465
+97,910
| +128% | +$1.64M |
|
2191
LendingTree
TREE
$978M
| $2.93M | ﹤0.01% |
75,564
+689
| +0.9% | +$26.7K |
|
2192
Spyre Therapeutics
SYRE
$945M
| $2.93M | ﹤0.01% |
125,668
+378
| +0.3% | +$8.8K |
|
2193
Energy Fuels
UUUU
$2.75B
| $2.91M | ﹤0.01% |
567,905
| – | – |
|
2194
Schrodinger
SDGR
$1.37B
| $2.9M | ﹤0.01% |
150,576
| – | – |
|
|
ARDT
2195
Ardent Health, Inc.
ARDT
$1.87B
| $2.89M | ﹤0.01% |
169,475
+116,610
| +221% | +$1.99M |
|
2196
TransAlta
TAC
$3.75B
| $2.89M | ﹤0.01% |
204,605
-6,916
| -3% | -$97.8K |
|
|
CBL
2197
CBL Properties
CBL
$993M
| $2.89M | ﹤0.01% |
98,213
+13,127
| +15% | +$386K |
|
2198
10x Genomics
TXG
$1.57B
| $2.89M | ﹤0.01% |
201,061
-73
| -0% | -$1.05K |
|
|
PSTX
2199
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $2.87M | ﹤0.01% |
299,297
-5,314
| -2% | -$51K |
|
2200
Driven Brands
DRVN
$3B
| $2.86M | ﹤0.01% |
177,357
-3,100
| -2% | -$50K |
|